
Benjamine’s Bio
Benjamine Liu is the co-founder and CEO of Formation Bio, an AI-native pharma company based in NYC.
Benjamine received his DPhil at Oxford as a Rhodes Scholar, conducting his work with Sir Simon Lovestone. His doctoral thesis leveraged machine-learning, AI, and scaled healthcare data — genomics, proteomics, transcriptomics, metabolomics, imaging — to develop diagnostics and therapeutics for Parkinson’s and Alzheimer’s disease.
During his graduate work, he observed the way clinical trials bottlenecked the development of new treatments for patients, compelling him to start Formation Bio.
Before Formation Bio, Benjamine graduated from Yale where he was awarded the college’s highest honor at graduation and received his MPhil with distinction in Computational Biology from the Department of Applied Mathematics and Theoretical Physics at Cambridge as a Paul Melon Fellow. Ben is also an advisor to Harvard Business School’s MS/MBA in biotechnology.